Objective: Three cases of rare alleles of HLA-C with zero mismatched PCR-SBT results were analyzed by full-length sequencing to determine the true genotypes.
Methods: Three rare HLA-C alleles with zero mismatched PCR-SBT results were screened from clinical transplant matching samples, and the full-length sequence was detected by next-generation sequencing technology.
Results: The results of PCR-SBT typing of 3 samples were: HLA-C*03:04, 12:167; HLA-C*07:291, 15:02; HLA-C*01:43, 08:16. Other alleles were not in the CWD table of common and confirmed HLA alleles in China (version 2.3) except common allele HLA-C*03:04, HLA-C*15:02. NGS full-length sequencing revealed that the HLA-C genotypes of the three samples were a combination of common alleles and novel alleles, and the three novel alleles had a base mutation in exons 6, 2, and 4, respectively. The novel allele sequences have been submitted to the Genbank database (MK629722, MK335474, MK641803), which were officially named HLA-C*03:04:74, HLA-C*15:192, HLA-C*08:01:25 by the WHO HLA Nomenclature Committee. The HLA high-resolution typing results of 3 samples were: HLA-C*03:04:74, HLA-C*12:03; HLA-C*07:02, HLA-C*15:192; HLA-C*01:02, HLA-C*08:01:25.
Conclusion: HLA typing results containing rare alleles should be treated cautiously, and the full-length sequence should be verified by NGS or cloning. The laboratory finally confirmed that the 3 cases of PCR-SBT zero mismatch HLA-C genotypes are the combination of common alleles and novel alleles by NGS sequencing, which provides an accurate basis for clinical transplantation matching and enriches the human HLA genetic database.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.19746/j.cnki.issn.1009-2137.2022.04.038 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Risk prediction and function evaluation by T-cell epitope model and expression model of HLA-DPB1 mismatching in unrelated-donor hematopoietic stem cell transplantations].
Zhonghua Yi Xue Za Zhi
March 2024
Blood Center of Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an 710061, China.
To evaluate the risk prediction and assessment function of HLA-DPB1 T-cell epitope (TCE) model and expression model in human leukocyte antigen (HLA)-matched unrelated hematopoietic stem cell transplantation (MUD-HSCT) with HLA-DPB1 mismatching. A total of 364 (182 pairs) potential MUD-HSCT donors and recipients confirmed by HLA high-resolution typing in Shaanxi Blood Center from 2016 to 2019 were analyzed retrospectively. Of the 182 recipients, there were 121 males and 61 females with an average age of (26.
View Article and Find Full Text PDF[Genetic analysis of a Chinese pedigree with an allele dropout at the HLA-B locus].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
January 2024
Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong 518020, China.
Article Synopsis
- The study aims to identify a deletion mutation in the HLA-B gene within a Chinese family with a patient suffering from acute myeloid leukemia.
- Methods used include PCR techniques for routine HLA testing and next-generation sequencing (NGS) for confirming genetic variants.
- Results revealed inconsistencies in HLA-B typing between the patient and her daughter, ultimately identifying a 9 bp deletion in the HLA-B gene that impacted PCR-SBT accuracy.
Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort Study.
Front Immunol
August 2022
Infectious Diseases Department, Hospital Clinic de Barcelona - Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Article Synopsis
- The study investigates the role of genetic polymorphisms in the innate immune system that may increase the risk of cytomegalovirus (CMV) infection in transplant patients, particularly those receiving organs from CMV-positive donors.
- A total of 116 CMV-seronegative transplant recipients were monitored for CMV infection post-surgery, with notable findings that 53% experienced some level of infection, including asymptomatic and symptomatic cases.
- A polygenic score based on specific genetic markers was developed to predict the risk of CMV disease, showing moderate effectiveness (AUC of 0.68), emphasizing the need for additional validation studies to enhance predictive models for at-risk transplant recipients.
[Exclusion of HLA-C Genotype with Zero Mismatched PCR-SBT Results by Next Generation Sequencing].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
August 2022
Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen 518020, Guangdong Province, China E-mail:
Objective: Three cases of rare alleles of HLA-C with zero mismatched PCR-SBT results were analyzed by full-length sequencing to determine the true genotypes.
Methods: Three rare HLA-C alleles with zero mismatched PCR-SBT results were screened from clinical transplant matching samples, and the full-length sequence was detected by next-generation sequencing technology.
Results: The results of PCR-SBT typing of 3 samples were: HLA-C*03:04, 12:167; HLA-C*07:291, 15:02; HLA-C*01:43, 08:16.
The Potential Significance of ABO Genotyping for Donor Selection in Kidney Transplantation.
Front Immunol
June 2021
Division of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Background: The ABO blood group system is clinically important in kidney transplantation, but ABO genotyping fails to attract sufficient attention in some countries and regions. We identified one case of early graft dysfunction due to an ABO genotype mismatch. Here, we performed ABO genotyping in blood samples, analyzed grouping discrepancies, and investigated the weak A subgroup frequency in kidney transplantation candidates.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!